Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in IntangiblesChange in InventoryGains from Investment SecuritiesNet Debt Issuances and RepaymentsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Free Cash Flow: 2022-2023

Historic Free Cash Flow for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$4.7 million.

  • Mainz Biomed N.V's Free Cash Flow rose 1.21% to -$4.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$21.9 million, marking a year-over-year decrease of 48.54%. This contributed to the annual value of -$17.2 million for FY2024, which is 25.68% up from last year.
  • Per Mainz Biomed N.V's latest filing, its Free Cash Flow stood at -$4.7 million for Q4 2023, which was up 28.44% from -$6.5 million recorded in Q3 2023.
  • Mainz Biomed N.V's Free Cash Flow's 5-year high stood at -$2.8 million during Q1 2022, with a 5-year trough of -$6.5 million in Q3 2023.
  • Over the past 2 years, Mainz Biomed N.V's median Free Cash Flow value was -$4.7 million (recorded in 2022), while the average stood at -$4.6 million.
  • Examining YoY changes over the last 5 years, Mainz Biomed N.V's Free Cash Flow showed a top increase of 1.21% in 2023 and a maximum decrease of 105.19% in 2023.
  • Over the past 2 years, Mainz Biomed N.V's Free Cash Flow (Quarterly) stood at -$4.7 million in 2022, then grew by 1.21% to -$4.7 million in 2023.
  • Its Free Cash Flow stands at -$4.7 million for Q4 2023, versus -$6.5 million for Q3 2023 and -$5.1 million for Q2 2023.